Lappaconitine
Alternative Names: AllapinineLatest Information Update: 21 Apr 2022
At a glance
- Originator Shanghai Institute of Materia Medica
- Developer Nonindustrial source; Shanghai Institute of Materia Medica
- Class Antiarrhythmics; Non-opioid analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 21 Apr 2022 Discontinued - Phase-II for Arrhythmias in China (unspecified route)
- 21 Apr 2022 Discontinued - Phase-II for Arrhythmias in Russia (unspecified route)
- 12 Jan 2001 No-Development-Reported for Arrhythmias in China (Unknown route)